Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May 18;72(10):1823-1825.
doi: 10.1093/cid/ciaa982.

Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir

Gene D Morse  1
Affiliations
Editorial

Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir

Gene D Morse. Clin Infect Dis. .
No abstract available

Keywords: dolutegravir; drug interaction; efavirenz; implementation research.

PubMed Disclaimer

Comment on

References

    1. Bos JC, Prins JM, Misticio MC, et al. . Population pharmacokinetics with Monte Carlo simulations of gentamicin in a population of severely ill adult patients from sub-Saharan Africa. Antimicrob Agents Chemother 2019; 63:e02328–18. - PMC - PubMed
    1. Buzibye A, Musaazi J, von Braun A, et al. . Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study. AIDS Res Ther 2019; 16:39. - PMC - PubMed
    1. Denti P, Martinson N, Cohn S, et al. . Population pharmacokinetics of rifampin in pregnant women with tuberculosis and HIV coinfection in Soweto, South Africa. Antimicrob Agents Chemother 2015; 60:1234–41. - PMC - PubMed
    1. Gutierrez MM, Pillai G, Felix S, et al. . Building capability for clinical pharmacology research in sub-Saharan Africa. Clin Pharmacol Ther 2017; 102:786–95. - PubMed
    1. Mahomed S, Garrett N, Capparelli E, et al. . Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial. BMJ Open 2019; 9:e030283. - PMC - PubMed